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We read with interest the article by Sun et al entitled "Platelet to Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention." 1 The authors 1 found that the platelet to lymphocyte ratio is higher in patients with contrast-induced nephropathy (CIN). They stated that all patients received intravenous hydration with isotonic saline (0.9% sodium chloride, 1 mL/kg/h, or 0.5 mL/kg/h in cases of overt heart failure), for 12 hours after the procedure. Did these patients receive intravenous hydration before the coronary angiography?
A variety of agents, such as N-acetylcysteine (NAC), have been used to prevent CIN. Tepel et al 2 evaluated 83 patients undergoing contrast-enhanced computed tomography scanning. Only participants with serum creatinine >1.2 mg/dL or creatinine clearance <50 mL/min were studied. Randomization was followed by double-blind treatment with either oral NAC 600 mg twice daily on the day before and the day of the computed tomography scan or with placebo. Contrast-induced nephropathy occurred in 21% of placebo participants compared with 2% in the NAC group (P ¼ .01). 2 In contrast, Durham et al compared placebo or NAC 1200 mg orally with doses 1 hour before coronary angiography and 3 hours after the procedure. They found no significant difference in the rate of CIN between the NAC and placebo groups (26.3% vs 22.0%). 3 However, other studies showed that NAC reduced the risk of CIN by 90.5, 86.6, 67.7, and 82.2%, respectively. 4-7 Did Sun et al treat their patients with NAC? This information will affect the interpretation of the study.
ORCID iD
Ç agri Yayla http://orcid.org/0000-0002-5302-4052.
